MEDICAGO INC has a total of 433 patent applications. It increased the IP activity by 100.0%. Its first patent ever was published in 2000. It filed its patents most often in EPO (European Patent Office), Canada and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and foods and drinks are VIROGENETICS CORP, GENVEC INC and BENITEC BIOPHARMA LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 45 | |
#2 | Canada | 39 | |
#3 | Australia | 35 | |
#4 | China | 35 | |
#5 | WIPO (World Intellectual Property Organization) | 35 | |
#6 | United States | 33 | |
#7 | Republic of Korea | 23 | |
#8 | Israel | 21 | |
#9 | Brazil | 20 | |
#10 | Mexico | 20 | |
#11 | Singapore | 19 | |
#12 | New Zealand | 15 | |
#13 | South Africa | 14 | |
#14 | Hong Kong | 12 | |
#15 | Japan | 12 | |
#16 | Taiwan | 10 | |
#17 | Hungary | 6 | |
#18 | Malaysia | 6 | |
#19 | Russian Federation | 6 | |
#20 | India | 4 | |
#21 | Morocco | 4 | |
#22 | Philippines | 4 | |
#23 | EAPO (Eurasian Patent Organization) | 3 | |
#24 | Tunisia | 3 | |
#25 | Argentina | 2 | |
#26 | Costa Rica | 2 | |
#27 | Iceland | 2 | |
#28 | Slovenia | 2 | |
#29 | Egypt | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Foods and drinks | |
#4 | Computer technology | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | New plants | |
#6 | Fermentation | |
#7 | Enzymes | |
#8 | Electric digital data processing | |
#9 | Horticulture | |
#10 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Vezina Louis-Philippe | 223 |
#2 | Couture Manon | 202 |
#3 | Lavoie Pierre-Olivier | 181 |
#4 | D'Aoust Marc-Andre | 124 |
#5 | D Aoust Marc-Andre | 120 |
#6 | Dargis Michele | 87 |
#7 | Landry Nathalie | 83 |
#8 | Trepanier Sonia | 40 |
#9 | Paquet Dany | 39 |
#10 | Ors Frederic | 38 |
Publication | Filing date | Title |
---|---|---|
WO2020168424A1 | Rotavirus vp7 fusion proteins and rotavirus-like particles comprising them | |
TW202018084A | Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins | |
AU2019295495A1 | Influenza virus hemagglutinin mutants | |
BR112020018639A2 | PLANT EXPRESSION POTENTIATOR | |
AU2018375695A1 | Modified norovirus VP1 proteins and VLPS comprising modified norovirus VP1 proteins | |
WO2020010428A1 | Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins | |
EP3601580A1 | Norovirus fusion proteins and vlps comprising norovirus fusion proteins | |
EP3519563A1 | Modifying n-glycosylation of plant proteins using gdp-4-dehydro-6-deoxy-d-mannose reductase (rmd) | |
WO2017000074A1 | Jasmonic acid pathway activator | |
WO2016115630A1 | Rotavirus-like particle production in plants | |
US2017204427A1 | Modifying protein production in plants | |
AU2015202195A1 | New influenza virus immunizing epitope | |
CA2943796A1 | Modified cpmv enhancer elements | |
US2015218579A1 | Increasing protein yield in plants | |
AU2015205805A1 | CPMV enhancer elements | |
CA2907591A1 | Influenza virus-like particle production in plants | |
CN104755614A | Picornavirus-like particle production in plants | |
CN104363752A | Plant infiltration tray | |
EP3321358A2 | Rotavirus-like particle production in plants | |
AU2013220904A1 | Plant infiltration device |